CHICAGO, Jan. 15, 2020 — (PRNewswire) — According to the new market research report " Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024", published by MarketsandMarkets™, the global Cardiac Mapping Market size is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405

The inclusion of new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population are the key drivers of the cardiac mapping systems market.  

Contact cardiac mapping are estimated to account for the largest share of the cardiac mapping systems product market in 2019

The contact Cardiac Mapping Market is segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment is divided further into electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of the cardiac mapping systems market in 2019. The advantages offered by contact cardiac mapping systems, such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment and requirement of just a few beats recordings might uncover the arrhythmia circuit, are the major factors driving the growth of this product segment.

Browse in-depth TOC on  " Cardiac Mapping Market "
102 – Tables
27 – Figures  
135 – Pages

Atrial fibrillation is the primary application areas of the global Cardiac Mapping Market

The market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.

Get 10% Customization on this Research Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=89853405

The APAC Cardiac Mapping Market to grow at the highest CAGR during the forecast period

While North America is expected to dominate the global cardiac mapping industry in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, and growing demand for advanced technologies.

The major players operating in the Cardiac Mapping Market include Biosense Webster (US), Abbott (US),  and Boston Scientific Corporation (US). The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical  (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System  (Germany).

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Get Special Pricing on Bundle Reports:
https://www.marketsandmarkets.com/RequestBundleReport.asp?id=89853405

Browse Related Reports:

Cardiac Monitoring & Cardiac Rhythm Management Devices Market  CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024

Electrophysiology Market  by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ICE, X-ray)) & Indication (AF, VT, WPW) - Global Forecasts to 2019

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

View original content: http://www.prnewswire.com/news-releases/cardiac-mapping-market-worth-2-1-billion-by-2024--exclusive-report-by-marketsandmarkets-300987350.html

SOURCE MarketsandMarkets